Sim MS - Search Results

1

A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer.

Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, Karlan BY, Orsulic S. Cheon DJ, et al. Among authors: sim ms. Clin Cancer Res. 2014 Feb 1;20(3):711-23. doi: 10.1158/1078-0432.CCR-13-1256. Epub 2013 Nov 11. Clin Cancer Res. 2014. PMID: 24218511 Free PMC article.

2

FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.

Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, Walter MA, Martens JW, Richardson AL, Giuliano AE, Cui X. Ray PS, et al. Among authors: sim ms. Cancer Res. 2010 May 15;70(10):3870-6. doi: 10.1158/0008-5472.CAN-09-4120. Epub 2010 Apr 20. Cancer Res. 2010. PMID: 20406990

3

Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells.

Qu Y, Wang J, Sim MS, Liu B, Giuliano A, Barsoum J, Cui X. Qu Y, et al. Among authors: sim ms. Breast Cancer Res Treat. 2010 Jun;121(2):311-21. doi: 10.1007/s10549-009-0470-6. Epub 2009 Jul 16. Breast Cancer Res Treat. 2010. PMID: 19609669

4

Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.

Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS. Kitago M, et al. Among authors: sim ms. Clin Cancer Res. 2009 May 1;15(9):2988-94. doi: 10.1158/1078-0432.CCR-08-3172. Epub 2009 Mar 31. Clin Cancer Res. 2009. PMID: 19336521 Free PMC article.

5

Prognostic value of basal phenotype in HER2-overexpressing breast cancer.

Bagaria SP, Ray PS, Wang J, Kropcho L, Chung A, Sim MS, Shamonki JM, Martino S, Cui X, Giuliano AE. Bagaria SP, et al. Among authors: sim ms. Ann Surg Oncol. 2012 Mar;19(3):935-40. doi: 10.1245/s10434-011-2032-5. Epub 2011 Aug 31. Ann Surg Oncol. 2012. PMID: 21879270

6

Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.

Bagaria SP, Ray PS, Sim MS, Ye X, Shamonki JM, Cui X, Giuliano AE. Bagaria SP, et al. Among authors: sim ms. JAMA Surg. 2014 Feb;149(2):125-9. doi: 10.1001/jamasurg.2013.3181. JAMA Surg. 2014. PMID: 24306257

7

Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.

Ray PS, Bagaria SP, Wang J, Shamonki JM, Ye X, Sim MS, Steen S, Qu Y, Cui X, Giuliano AE. Ray PS, et al. Among authors: sim ms. Ann Surg Oncol. 2011 Dec;18(13):3839-47. doi: 10.1245/s10434-011-1657-8. Epub 2011 Mar 18. Ann Surg Oncol. 2011. PMID: 21424368

8

CpG island methylator phenotype predicts progression of malignant melanoma.

Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS. Tanemura A, et al. Among authors: sim ms. Clin Cancer Res. 2009 Mar 1;15(5):1801-7. doi: 10.1158/1078-0432.CCR-08-1361. Epub 2009 Feb 17. Clin Cancer Res. 2009. PMID: 19223509 Free PMC article.

9

High levels of secreted frizzled-related protein 1 correlate with poor prognosis and promote tumourigenesis in gastric cancer.

Qu Y, Ray PS, Li J, Cai Q, Bagaria SP, Moran C, Sim MS, Zhang J, Turner RR, Zhu Z, Cui X, Liu B. Qu Y, et al. Among authors: sim ms. Eur J Cancer. 2013 Nov;49(17):3718-28. doi: 10.1016/j.ejca.2013.07.011. Epub 2013 Aug 5. Eur J Cancer. 2013. PMID: 23927957

10

Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.

Hoshimoto S, Takeuchi H, Ono S, Sim MS, Huynh JL, Huang SK, Marzese DM, Kitagawa Y, Hoon DS. Hoshimoto S, et al. Among authors: sim ms. J Thorac Oncol. 2015 Mar;10(3):509-17. doi: 10.1097/JTO.0000000000000441. J Thorac Oncol. 2015. PMID: 25514805 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page